Global Challenge of Chronic Pain
Chronic pain is one of the leading causes of disability worldwide, impacting over 20% of people in the United States. Despite available treatments, one in five patients continues to suffer without adequate relief. Many current options bring unwanted side effects and carry the risk of long-term opioid dependence, while failing to address the emotional and psychological burden of living with chronic pain.
A Promising New Solution
Effective pain management often requires more than medication. Multidisciplinary programs that combine pharmacotherapy with cognitive behavioural therapy and psychological support are essential to address both the physical and mental impact of chronic pain.
Cyrene Health Therapeutics is advancing a unique approach to chronic pain treatment. We have developed a novel psilocybin-based compound, delivered through an innovative drug delivery system, specifically designed to meet the complex, multidisciplinary needs of chronic pain patients.
While psilocybin is under investigation for psychological conditions such as PTSD, anxiety, and depression, very few studies have explored its potential for treating chronic pain. We are committed to being a pioneer in clinical trials in biotechnology, working to demonstrate that our unique psilocybin therapy is not only safe but highly effective, with a safety profile that is far more tolerable than opioid analgesics.
Transforming Treatment With Science
Cyrene Health Therapeutics is advancing its commitment to innovative treatment solutions by launching clinical trials to evaluate the safety and effectiveness of psychedelic-based therapeutics with novel delivery methods. Led by an expert team in medicine, clinical research, and pharmacology, we are driven to develop groundbreaking therapies and investigational drugs that address chronic pain and neuro inflammatory conditions.
Join the Future of Clinical Trials
If you’re a healthcare professional, investor, or organization interested in clinical research initiatives, we’d be glad to provide insights into our ongoing and future trials. Contact us to discuss how clinical research can open new pathways in treatment management and explore how you can engage with these advancements in biotechnology.